Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC : short communication

Guardado en:

Detalles Bibliográficos
Autores principales:	Frederiksen, Kristian Steen (Autor) , Boada, Mercè (Autor) , Frölich, Lutz (Autor) , Kramberger, Milica (Autor) , Scarmeas, Nikolaos (Autor) , Vijverberg, Everard (Autor) , Visser, Pieter Jelle (Autor) , Waldemar, Gunhild (Autor) , Westman, Eric (Autor) , Zetterberg, Henrik (Autor) , Engelborghs, Sebastiaan (Autor) , Jessen, Frank (Autor)
Formato:	Article (Journal) Editorial
Lenguaje:	inglés
Publicado:	August 2026
In:	The journal of prevention of Alzheimer's disease Year: 2026, Volumen: 13, Número: 7, Pages: 1-3
ISSN:	2426-0266
DOI:	10.1016/j.tjpad.2026.100598
Acceso en línea:	Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.tjpad.2026.100598 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2274580726001238
Notas de Autor:	Kristian Steen Frederiksen, Mercè Boada, Lutz Frölich, Milica Kramberger, Nikolaos Scarmeas, Everard Vijverberg, Pieter Jelle Visser, Gunhild Waldemar, Eric Westman, Henrik Zetterberg, Sebastiaan Engelborghs, Frank Jessen

Descripción
Notas:	Online verfügbar: 18. Mai 2026, Artikelversion: 18. Mai 2026 Gesehen am 23.06.2026
Descripción Física:	Online Resource
ISSN:	2426-0266
DOI:	10.1016/j.tjpad.2026.100598

Ejemplares similares